Market Overview

ARIAD Pharmaceuticals, Inc. (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2016
Pre-Market
EPS:
REV:
-0.29
29.07M
-0.19
42.93M
-0.12
46.016M
3684.21%
718.84%
Q2 2016
Pre-Market
EPS:
REV:
-0.33
29.238M
-0.11
60.64M
-0.06
68.125M
45.45%
12.34%
Q1 2016
Pre-Market
EPS:
REV:
-0.28
23.991M
-0.27
43.06M
-0.23
35.597M
14.81%
-17.33%
Q4 2015
Pre-Market
EPS:
REV:
-0.03
66.835M
-0.31
44.79M
-0.32
36.505M
-3.23%
-18.5%
Q3 2015
Pre-Market
EPS:
REV:
-0.27
14.7M
-0.23
46.09M
-0.29
29.07M
-26.09%
-36.93%
Q2 2015
Pre-Market
EPS:
REV:
-0.30
12.1M
-0.27
33.24M
-0.33
29.238M
-22.22%
-12.04%
Q1 2015
Pre-Market
EPS:
REV:
-0.27
11.8M
-0.26
27.26M
-0.28
23.991M
-7.69%
-11.99%
Q4 2014
Pre-Market
EPS:
REV:
-0.40
-0.11
47M
-0.03
66.835M
72.73%
42.2%
Q3 2014
Pre-Market
EPS:
REV:
-0.36
16.73M
-0.30
16.46M
-0.27
14.7M
10%
-10.69%
Q2 2014
Pre-Market
EPS:
REV:
-0.37
14.01M
-0.29
13.87M
-0.30
12.1M
-3.45%
-12.76%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!